CLINICAL_TRIALS ClinicalTrials.gov record update

Double-Blind, Placebo-Controlled Crossover Trial on the Safety and Efficacy of Sustained-Release Dalfampridine in Transverse Myelitis (Re-Launch)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02166346
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:57.043319+00:00
Published At: 2018-04-17T00:00:00+00:00
Record Updated At: 2018-04-17
Results Posted At: 2018-04-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Transverse Myelitis", "Neuromyelitis Optica", "Idiopathic Transverse Myelitis", "Myelitis NOS"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-04-17"
protocolSection.identificationModule.nctId: "NCT02166346"
protocolSection.identificationModule.officialTitle: "Double-Blind, Placebo-Controlled Crossover Trial on the Safety and Efficacy of Sustained-Release Dalfampridine in Transverse Myelitis (Re-Launch)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-04-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.